ArticleMethods in molecular biology (Clifton, N.J.)2026
Quantification of the Redox State of Integrin Disulfide Bonds.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We have developed a mass spectrometry-based method to quantify the redox state of protein disulfide bonds using a pair of isotopic alkylators. This technique can be applied in several contexts to investigate disulfide bond regulation in integrins. It may be used to identify disulfide-bond targets of vascular thiol isomerases, such as the two disulfide bonds in the β2 subunit of the integrin Mac-1 that are modulated by protein disulfide isomerase (PDI), or to evaluate the redox state of wild-type and mutant αIIbβ3 integrins recombinantly expressed in mammalian cells. Additionally, the method enables direct assessment of disulfide bond redox states in platelet integrins under native conditions. These streamlined protocols eliminate the immunoprecipitation steps included in previous workflows, significantly reducing both the time and cost of sample preparation and removing the dependency on high-affinity antibodies. In particular, the exclusion of immunoprecipitation in the platelet protocol ensures that no selection bias is introduced into the protein pool, allowing for a more accurate quantification of endogenous disulfide redox states in platelet proteins.
Indexed as
Identifiers
42681362What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.